Relevant literature was identified through a structured search strategy in significant databases, including PubMed, Scopus, and Web of Science, using keywords and phrases such as “PARP inhibitors,” “advanced ovarian cancer,” and “treatment outcomes.” The search was limited to articles published in the last decade to ensure the inclusion of recent advancements and clinical data. Here, PARP1 is linked to ovarian carcinoma.